盤中異動 | 騰盛博藥-B盤中上漲8%,報於39.25港元
2021年11月23日10時0分,騰盛博藥-B(HK02137)盤中上漲8%,報於39.25港元,成交額達4684.65萬港元,換手率達到0.09%。
11月19日訊,11月19日恆生指數公司公佈最新一期指數檢討結果,將騰盛博藥、醫脈通、海倫司納入恆生綜合指數,成份股數目由500只增加至503只。所有變動將於2021年12月6日(星期一)起生效。
11月15日,中金:首予騰盛博藥-B(02137)“跑贏行業”評級,目標價31港元。
盈立趨勢長盈模型最近一次交易信號,2021年11月15日出現關注信號,觸發價格爲29.75港元(信號僅供參考)。
uSMART智能寫手的信息、數據均來自媒體公開報道,智能寫手不能保證其完全準確,內容僅供參考,不構成投資建議。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.